China Molecular Diagnostics Market is projected US$ 1.8 Billion by 2024

Access full Research:
https://www.renub.com/china-molecular-diagnostics-market-test-volume-and-forecast-491-p.php

Get Free Customization in This Report

China Molecular Diagnostics Market is projected to reach US$ 1.8 Billion by the end of year 2024. Molecular diagnostics is a technique which is used for the molecular biological detection of any change in the structure or expression of patient’s genetic material. Molecular diagnostics plays an essential role in the detection and identification of various diseases and has gained more public & healthcare specialist attention than ever before. Today, Molecular diagnostics is changing the face of clinical laboratories by offering easy to use automated molecular systems that provide rapid results with less hands-on time.
China Molecular Diagnostics Market is growing rapidly due to the rising incidence of cancer and infectious diseases in the region. In addition; growing wealthy middle class population, who now are willing to pay more in availing better healthcare facilities and aging population who are more vulnerable to communicable diseases and the development in Chinese healthcare infrastructure are some other factors which are expected to drive China Molecular Diagnostics Market to a new record in the forthcoming years.

Request a free sample copy of the report: https://www.renub.com/contactus.php

Renub Research report titled “China Molecular Diagnostics Market, Volume, by Application [Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV), and Genetic Disease Testing (Blood Screening, HLA)]” provides a complete analysis of China Molecular Diagnostics Market.

By Application – Oncology and Infectious Disease Driving the China Molecular Diagnostics Market
The report studies the market and volume of the following Molecular Diagnostics segments: Oncology Testing (Breast Cancer, Colorectal Cancer, Prostate Cancer), Infectious Disease Testing (Virology, HPV) and Genetic Disease Testing (Blood Screening, HLA). Due to the rising cancer cases and infectious diseases in the China, it is believed that Oncology testing and Infectious disease testing leads the China Molecular Diagnostics Market in terms of both market & volume.
The report China Molecular Diagnostics Market has been studied from 7 viewpoints:
1) Market & Forecast
2) Volume & Forecast
3) Segments – Market Share & Forecast
4) Segments – Volume Share & Forecast
5) Profiles of Private Clinical Labs and Diagnostic Services
6) Growth Drivers for China Molecular Diagnostics
7) Challenges for China Molecular Diagnostics

This market research report provides a complete analysis of the China Molecular Diagnostics Market, Volume, Growth Drivers, Challenges, and their projections for the upcoming years.

Segment Covered in this report are as follows:
Oncology Testing Market and Volume
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer

Infectious Disease Testing Market and Volume
• Virology
• HPV

Genetic Testing Market and Volume
• Blood Screening
• HLA

Profiles of Private Clinical Labs and Diagnostic Services Companies in China
• Zhejiang Di’an Diagnostics Technology Co., Ltd
• ADICON Clinical Laboratories
• Guangzhou Kingmed Diagnostics Center Co. Ltd.
• Kindstar Global (Privately held)
• BGI-Shenzhen (Privately held)
• OriGene Technologies (Privately held)

Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.